Lenvima (Lenvatinib) Approved for Additional Indication of Unresectable Thymic Carcinoma in Japan
TOKYO, Mar 23, 2021 ̵ […]
TOKYO, Mar 23, 2021 ̵ […]
TOKYO, Mar 23, 2021 ̵ […]
TOKYO, Mar 23, 2021 ̵ […]
TOKYO, Mar 22, 2021 ̵ […]
TOKYO, Mar 22, 2021 ̵ […]
TOKYO, Mar 19, 2021 ̵ […]
TOKYO, Mar 19, 2021 ̵ […]
TOKYO, Mar 19, 2021 ̵ […]
TOKYO, Mar 18, 2021 ̵ […]
TOKYO, Mar 18, 2021 ̵ […]
TOKYO, Mar 18, 2021 ̵ […]
TOKYO, Mar 17, 2021 ̵ […]
TOKYO, Mar 17, 2021 ̵ […]
TOKYO, Mar 16, 2021 ̵ […]
TOKYO, Mar 11, 2021 ̵ […]
TOKYO, Mar 10, 2021 ̵ […]
KAWASAKI, Japan, Mar 10, […]
TOKYO, Mar 10, 2021 ̵ […]
TOKYO, Mar 9, 2021 – […]
TOKYO, Mar 9, 2021 – […]
TOKYO, Mar 8, 2021 – […]
TOKYO, Mar 8, 2021 – […]
TOKYO, Mar 5, 2021 – […]
TOKYO, Mar 4, 2021 – […]
TOKYO, Mar 4, 2021 – […]